PATRICK DEVAL L
Insider CIK 1053466 · AMWL Director · TWLO Director · GBT Director · TOST Director · CERE Director · GRNA
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TWLO TWILIO INC | A Award | 2026-09-15 | 2026-09-17 | 337 | — | $0 | 19,055 | SEC↗ |
| TWLO TWILIO INC | A Award | 2026-09-15 | 2026-09-17 | 337 | — | $0 | 19,055 | SEC↗ |
| TWLO TWILIO INC | A Award | 2026-06-15 | 2026-06-17 | 391 | — | $0 | 18,718 | SEC↗ |
| TOST Toast, Inc. | M Exercise deriv | 2026-06-12 | 2026-06-16 | 5,256 | — | $0 | 0 | SEC↗ |
| TOST Toast, Inc. | A Award deriv | 2026-06-12 | 2026-06-16 | 8,888 | — | $0 | 8,888 | SEC↗ |
| TOST Toast, Inc. | M Exercise deriv | 2026-06-12 | 2026-06-16 | 5,256 | — | $0 | 14,968 | SEC↗ |
| TWLO TWILIO INC | A Award | 2026-03-15 | 2026-03-17 | 673 | — | $0 | 18,327 | SEC↗ |
| TWLO TWILIO INC | A Award | 2025-12-15 | 2025-12-17 | 627 | — | $0 | 17,654 | SEC↗ |
| TWLO TWILIO INC | A Award | 2025-09-15 | 2025-09-17 | 763 | — | $0 | 17,027 | SEC↗ |
| TOST Toast, Inc. | A Award deriv | 2025-06-13 | 2025-06-17 | 5,256 | — | $0 | 5,256 | SEC↗ |
| TWLO TWILIO INC | A Award | 2025-06-09 | 2025-06-11 | 691 | — | $0 | 16,264 | SEC↗ |
| TOST Toast, Inc. | M Exercise deriv | 2025-06-06 | 2025-06-10 | 9,712 | — | $0 | 0 | SEC↗ |
| TOST Toast, Inc. | M Exercise deriv | 2025-06-06 | 2025-06-10 | 9,712 | — | $0 | 9,712 | SEC↗ |
| TWLO TWILIO INC | A Award | 2025-03-15 | 2025-03-18 | 618 | — | $0 | 15,573 | SEC↗ |
| TOST Toast, Inc. | S Sale | 2025-03-13 | 2025-03-14 | 34,222 | $33.01 | $1.13M | 13,260 | SEC↗ |
| TOST Toast, Inc. | S Sale | 2025-01-09 | 2026-04-23 | 1,667 | $36.95 | $61.6K | 45,815 | SEC↗ |
| TWLO TWILIO INC | A Award | 2024-12-15 | 2024-12-17 | 732 | — | $0 | 14,955 | SEC↗ |
| TWLO TWILIO INC | A Award | 2024-09-15 | 2024-09-17 | 1,240 | — | $0 | 14,223 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 49,794 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 10,461 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 3,282 | — | $0 | 10,461 | SEC↗ |
| TOST Toast, Inc. | M Exercise deriv | 2024-06-06 | 2024-06-10 | 11,593 | — | $0 | 0 | SEC↗ |
| TOST Toast, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 9,712 | — | $0 | 9,712 | SEC↗ |
| TOST Toast, Inc. | M Exercise | 2024-06-06 | 2024-06-10 | 11,593 | — | $0 | 47,482 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award | 2024-06-05 | 2024-06-07 | 10,461 | — | $0 | 13,743 | SEC↗ |
| TWLO TWILIO INC | A Award | 2024-06-05 | 2024-06-07 | 1,234 | — | $0 | 12,983 | SEC↗ |
| TWLO TWILIO INC | A Award | 2024-03-15 | 2024-03-19 | 1,195 | — | $0 | 11,749 | SEC↗ |
| TOST Toast, Inc. | M Exercise deriv | 2024-02-22 | 2024-02-26 | 7,645 | — | $0 | 0 | SEC↗ |
| TOST Toast, Inc. | M Exercise | 2024-02-22 | 2024-02-26 | 7,645 | — | $0 | 35,889 | SEC↗ |
| TWLO TWILIO INC | A Award | 2023-12-15 | 2023-12-19 | 1,153 | — | $0 | 10,554 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-11-01 | 2023-11-03 | 30,130 | — | $0 | 12,555 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-11-01 | 2023-11-03 | 30,130 | $25.00 | $753.3K | 3,282 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-11-01 | 2023-11-03 | 30,130 | $12.62 | $380.2K | 33,412 | SEC↗ |
| TWLO TWILIO INC | A Award | 2023-09-15 | 2023-09-19 | 1,192 | — | $0 | 9,401 | SEC↗ |
| GRNA GreenLight Biosciences Hol | J Other | 2023-07-24 | 2023-07-26 | 172,500 | — | $0 | 0 | SEC↗ |
| AMWL American Well Corp | A Award | 2023-06-22 | 2023-06-26 | 91,743 | — | $0 | 169,892 | SEC↗ |
| TWLO TWILIO INC | A Award | 2023-06-12 | 2023-06-14 | 1,310 | — | $0 | 8,209 | SEC↗ |
| TOST Toast, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 11,593 | — | $0 | 11,593 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-06-07 | 2023-06-09 | 13,780 | — | $0 | 13,780 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award | 2023-06-07 | 2023-06-09 | 3,282 | — | $0 | 3,282 | SEC↗ |
| TOST Toast, Inc. | M Exercise deriv | 2023-06-02 | 2023-06-05 | 11,292 | — | $0 | 0 | SEC↗ |
| TOST Toast, Inc. | M Exercise | 2023-06-02 | 2023-06-05 | 11,292 | — | $0 | 28,244 | SEC↗ |
| TWLO TWILIO INC | A Award | 2023-03-15 | 2023-03-17 | 1,101 | — | $0 | 6,899 | SEC↗ |
| TOST Toast, Inc. | M Exercise deriv | 2023-02-22 | 2023-02-24 | 7,640 | — | $0 | 7,645 | SEC↗ |
| TOST Toast, Inc. | M Exercise | 2023-02-22 | 2023-02-24 | 7,640 | — | $0 | 16,952 | SEC↗ |
| TWLO TWILIO INC | A Award | 2022-12-15 | 2022-12-19 | 1,565 | — | $0 | 5,798 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 625 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 5,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 5,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 3,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 5,247 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 9,037 | — | $0 | 0 | SEC↗ |
| TWLO TWILIO INC | A Award | 2022-09-15 | 2022-09-19 | 1,008 | — | $0 | 4,233 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2022-09-12 | 2022-09-14 | 47,705 | — | $0 | 42,685 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2022-09-12 | 2022-09-14 | 47,705 | $30.78 | $1.47M | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2022-09-12 | 2022-09-14 | 47,705 | $12.62 | $602.0K | 47,705 | SEC↗ |
| TWLO TWILIO INC | A Award | 2022-06-15 | 2022-06-17 | 736 | — | $0 | 3,225 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2022-06-14 | 2022-06-16 | 23,459 | — | $0 | 23,459 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-06-14 | 2022-06-16 | 3,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-06-14 | 2022-06-16 | 5,600 | — | $0 | 5,600 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-06-14 | 2022-06-16 | 3,600 | — | $0 | 3,600 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-06-14 | 2022-06-16 | 3,600 | — | $0 | 9,037 | SEC↗ |
| AMWL American Well Corp | A Award | 2022-06-13 | 2022-06-15 | 50,377 | — | $0 | 78,149 | SEC↗ |
| TOST Toast, Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 11,292 | — | $0 | 11,292 | SEC↗ |
| TWLO TWILIO INC | A Award | 2022-03-15 | 2022-03-17 | 431 | — | $0 | 2,489 | SEC↗ |
| TOST Toast, Inc. | M Exercise deriv | 2022-02-22 | 2022-02-24 | 7,645 | — | $0 | 15,285 | SEC↗ |
| TOST Toast, Inc. | M Exercise | 2022-02-22 | 2022-02-24 | 7,645 | — | $0 | 9,312 | SEC↗ |
| TWLO TWILIO INC | A Award | 2021-12-15 | 2021-12-17 | 263 | — | $0 | 2,058 | SEC↗ |
| AMWL American Well Corp | S Sale | 2021-11-02 | 2021-11-04 | 5,166 | $9.30 | $48.0K | 24,772 | SEC↗ |
| TOST Toast, Inc. | J Other deriv | 2021-10-27 | 2021-10-29 | 22,930 | — | $0 | 22,930 | SEC↗ |
| TOST Toast, Inc. | J Other deriv | 2021-10-27 | 2021-10-29 | 22,930 | — | $0 | 0 | SEC↗ |
| TOST Toast, Inc. | J Other deriv | 2021-09-24 | 2021-09-27 | 22,930 | — | $0 | 0 | SEC↗ |
| TOST Toast, Inc. | J Other deriv | 2021-09-24 | 2021-09-27 | 22,930 | — | $0 | 22,930 | SEC↗ |
| TOST Toast, Inc. | P Buy | 2021-09-24 | 2021-09-27 | 1,667 | $40.00 | $66.7K | 1,667 | SEC↗ |
| TWLO TWILIO INC | A Award | 2021-09-15 | 2021-09-17 | 210 | — | $0 | 1,795 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-06-17 | 2021-06-21 | 3,600 | — | $0 | 3,600 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-06-17 | 2021-06-21 | 5,600 | — | $0 | 5,600 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-06-17 | 2021-06-21 | 3,037 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-06-17 | 2021-06-21 | 3,037 | — | $0 | 5,437 | SEC↗ |
| TWLO TWILIO INC | A Award | 2021-06-16 | 2021-06-17 | 318 | — | $0 | 1,585 | SEC↗ |
| AMWL American Well Corp | A Award | 2021-06-15 | 2021-06-17 | 14,440 | — | $0 | 29,938 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2021-02-01 | 2021-02-03 | 90,390 | — | $0 | 90,390 | SEC↗ |
| TWLO TWILIO INC | A Award | 2021-01-13 | 2021-01-15 | 1,267 | — | $0 | 1,267 | SEC↗ |
| AMWL American Well Corp | A Award | 2020-11-02 | 2020-11-04 | 15,498 | — | $0 | 15,498 | SEC↗ |
| AMWL American Well Corp | P Buy | 2020-09-17 | 2022-04-22 | 8,000 | $18.00 | $144.0K | 8,000 | SEC↗ |
| AMWL American Well Corp | P Buy | 2020-09-17 | 2022-04-22 | 3,000 | $18.00 | $54.0K | 27,772 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-06-28 | 2020-06-29 | 2,400 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-06-28 | 2020-06-29 | 2,400 | — | $0 | 2,400 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-06-17 | 2020-06-19 | 5,247 | — | $0 | 5,247 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-06-17 | 2020-06-19 | 3,037 | — | $0 | 3,037 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-05-28 | 2020-06-01 | 625 | — | $0 | 625 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-05-28 | 2020-06-01 | 2,400 | — | $0 | 2,400 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-10-08 | 2019-10-10 | 5,357 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-10-08 | 2019-10-10 | 5,357 | $45.05 | $241.3K | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-10-08 | 2019-10-10 | 5,357 | $3.40 | $18.2K | 5,357 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-06-18 | 2019-06-20 | 4,800 | — | $0 | 4,800 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-06-18 | 2019-06-20 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-07-06 | 2018-07-10 | 15,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-07-06 | 2018-07-10 | 8,361 | — | $0 | 239 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-07-06 | 2018-07-10 | 15,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-07-06 | 2018-07-10 | 4,018 | — | $0 | 5,357 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-07-06 | 2018-07-10 | 42,379 | $43.40 | $1.84M | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-07-06 | 2018-07-10 | 4,018 | $3.40 | $13.7K | 42,379 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-07-06 | 2018-07-10 | 8,361 | $20.00 | $167.2K | 38,361 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-07-06 | 2018-07-10 | 15,000 | $20.00 | $300.0K | 30,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-07-06 | 2018-07-10 | 15,000 | $28.45 | $426.8K | 15,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-06-20 | 2018-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-07-25 | 2017-07-27 | 15,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-07-25 | 2017-07-27 | 12,053 | — | $0 | 9,375 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-07-25 | 2017-07-27 | 12,053 | $3.40 | $41.0K | 12,053 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-07-25 | 2017-07-27 | 15,000 | $18.85 | $282.8K | 27,053 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-07-25 | 2017-07-27 | 27,053 | $29.69 | $803.2K | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-06-20 | 2017-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2016-06-16 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GBT Global Blood Therapeutics, | P Buy | 2015-08-17 | 2016-01-07 | 2,500 | $20.00 | $50.0K | 2,500 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2015-08-11 | 2015-08-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2015-08-11 | 2015-08-13 | 8,600 | — | $0 | 8,600 | SEC↗ |